AbbVie Inc. Uncategorized Contracts & Agreements
32 Contracts & Agreements
- Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 20, 2024)
- AbbVie Non-Employee Directors Fee Plan, as amended and restated (Filed With SEC on August 4, 2022)
- Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 6, 2022)
- AbbVie Supplemental Savings Plan, as amended and restated (Filed With SEC on February 18, 2022)
- AbbVie Supplemental Pension Plan, as amended and restated (Filed With SEC on February 18, 2022)
- Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 18, 2022)
- Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 7, 2021)
- Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 7, 2021)
- Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 19, 2021)
- AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on May 8, 2020)
- Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 8, 2020)
- Amendment to the Transaction Agreement, dated as of May 5, 2020, between AbbVie Inc., Allergan plc and Venice Subsidiary, LLC (Filed With SEC on May 8, 2020)
- Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 21, 2020)
- AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on November 6, 2019)
- AbbVie Supplemental Pension Plan, as amended and restated (Filed With SEC on August 5, 2019)
- Transaction Agreement, dated as of June 25, 2019, between AbbVie, Allergan and Acquirer Sub (Filed With SEC on June 25, 2019)
- Expenses Reimbursement Agreement, dated as of June 25, 2019, between AbbVie and Allergan (Filed With SEC on June 25, 2019)
- Appendix III to the Rule 2.5 Announcement, dated as of June 25, 2019 (Conditions Appendix) (Filed With SEC on June 25, 2019)
- Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 3, 2019)
- Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 4, 2018)
- AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on February 16, 2018)
- ABBVIE SUPPLEMENTAL PENSION PLAN (Amended and Restated Effective as of January 1, 2016) ABBVIE SUPPLEMENTAL PENSION PLAN SECTION 1 INTRODUCTION (Filed With SEC on February 17, 2017)
- ABBVIE SUPPLEMENTAL SAVINGS PLAN (Amended and Restated Effective as of January 1, 2015) (Filed With SEC on February 19, 2016)
- ABBVIE NON-EMPLOYEE DIRECTORS FEE PLAN (Amended and Restated Effective as of May 6, 2016) (Filed With SEC on February 19, 2016)
- SUPPORT AGREEMENT (Filed With SEC on March 6, 2015)
- RECOMMENDED COMBINATION OF SHIRE PLC AND ABBVIE INC. (Filed With SEC on July 18, 2014)
- FIRST AMENDMENT TO LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT (Filed With SEC on February 21, 2014)
- FIRST AMENDMENT TO INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT (Filed With SEC on February 21, 2014)
- ABBVIE SUPPLEMENTAL SAVINGS PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)
- ABBVIE SUPPLEMENTAL PENSION PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)
- ABBVIE NON-EMPLOYEE DIRECTORS FEE PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)
- TAX SHARING AGREEMENT Between ABBOTT LABORATORIES on behalf of itself and the ABBOTT AFFILIATES and ABBVIE INC. on behalf of itself and the ABBVIE AFFILIATES (Filed With SEC on January 2, 2013)
